How the World’s Delay on Congo’s Ebola Outbreak Repeats Past Failures – And Why Speed Must Come First
- Global health experts are warning that the current Ebola outbreak in the Democratic Republic of the Congo (DRC) demands immediate, decisive action—yet past responses have repeatedly shown that...
- Sridhar’s urgency stems from a familiar pattern: the tendency to overanalyze and underact when outbreaks emerge.
- The DRC’s geography and political instability create unique challenges.
Global health experts are warning that the current Ebola outbreak in the Democratic Republic of the Congo (DRC) demands immediate, decisive action—yet past responses have repeatedly shown that hesitation costs lives. In a letter published May 19 in The Guardian, epidemiologist Devi Sridhar, a professor of global public health at the University of Edinburgh, argued that the world cannot afford to repeat the same delays that have plagued previous Ebola crises. Her call echoes lessons learned from the devastating 2014–2016 West African outbreak and smaller flare-ups in the DRC between 2018 and 2020.
Sridhar’s urgency stems from a familiar pattern: the tendency to overanalyze and underact when outbreaks emerge. “You can have it good, fast, or cheap—pick two,” she wrote, paraphrasing an engineering adage. In global health emergencies, she argues, the choice must be fast
first. The consequences of delay are stark. In 2014, the Ebola virus spread unchecked for months before international aid arrived, infecting nearly 30,000 people and killing over 11,000. In the DRC, where conflict, poor infrastructure, and mistrust of health workers have historically hindered responses, even smaller outbreaks have spiraled without swift intervention.
Why Speed Matters in Ebola Control
The DRC’s geography and political instability create unique challenges. Remote villages with limited access to healthcare, combined with armed conflict in some regions, make it difficult to deploy vaccines, medical supplies, and trained personnel quickly. Yet, as Sridhar notes, the tools to combat Ebola already exist. Experimental vaccines like rVSV-ZEBOV, developed by the Merck pharmaceutical company in collaboration with the World Health Organization (WHO), have shown high efficacy in clinical trials. During the 2018–2020 DRC outbreak, the vaccine was used in a ring vaccination strategy, targeting contacts of confirmed cases and their close contacts—a tactic that reduced transmission in some areas.

However, success depends on rapid mobilization. “We think too long before going in, despite knowing what is needed,” Sridhar wrote, referencing her firsthand experience advising on outbreak responses. The 2014 outbreak in West Africa exposed critical gaps: slow deployment of treatment centers, underfunded contact tracing, and insufficient community engagement. In the DRC, where outbreaks have become almost endemic, these failures have repeated themselves. Between 2018 and 2020, the country experienced multiple Ebola flare-ups, each requiring a fresh surge of international aid—yet each time, the response arrived too late to prevent widespread transmission.
The Human Cost of Delay
Ebola’s fatality rate can exceed 50% if untreated, and even with modern care, survival depends on early access to treatment. In the 2014 outbreak, many patients died waiting for beds in overwhelmed clinics. Health workers, already stretched thin, faced burnout and danger, with hundreds contracting the virus themselves. Communities in affected regions often reject health interventions due to fear, misinformation, or past trauma—such as forced vaccinations or aggressive quarantine measures. Without trust, containment efforts falter.
Sridhar’s letter highlights another critical factor: the economic and social ripple effects of Ebola. Beyond the immediate loss of life, outbreaks devastate local economies. Trade routes close, schools shut down, and healthcare systems collapse under the strain. In the DRC, where poverty rates exceed 70%, the long-term impact of an unchecked outbreak could push millions further into crisis. Yet, international funding and political will often wane once the media spotlight fades.
What Comes Next?
As of May 24, the DRC’s latest outbreak remains underreported in global headlines, but health officials warn it is no less urgent. The WHO has declared Ebola a public health emergency of international concern
in past outbreaks, but such declarations require coordinated action—something that has historically been slow to materialize. Sridhar’s call to action centers on three priorities:

- Prepositioning resources: Stockpiling vaccines, personal protective equipment (PPE), and treatment supplies in high-risk regions before an outbreak is confirmed.
- Strengthening local capacity: Investing in DRC’s health infrastructure to reduce reliance on international aid and improve rapid-response teams.
- Community engagement: Partnering with local leaders and trusted figures to build trust and ensure buy-in for containment measures.
Yet, as Sridhar acknowledges, political will remains the biggest hurdle. “If your neighbor’s house is on fire, you don’t wait and watch,” she wrote. The metaphor underscores the moral imperative: Ebola does not respect borders, and inaction in one region risks igniting a global crisis. With the DRC’s outbreak showing no signs of slowing, the question is no longer whether the world will act—but whether it will act in time.
For now, the focus remains on the DRC, where health workers, researchers, and local communities are on the front lines. The lessons from past outbreaks are clear: speed saves lives. Whether the world heeds them remains to be seen.
